Trial Profile

A first in man, phase I/IIa trial of CG-001 for Osteoarthritis (Prevention)

Status: Planning

Phase of Trial: Phase I/II

Latest Information Update: 07 Oct 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Oct 2020 According to a CartilaGen media release, the company received key early stage funding and recognition from Wellmark and MATTER which will bolster development of its preventive solution for PTOA at a crucial time as the company is set to begin this trial.
20 Sep 2019 New trial record
16 Sep 2019 According to an CartilaGen Media release, the company is planning a combined phase I/IIa first-in-human clinical trial to provide an effective solution for preventing post-traumatic osteoarthritis (PTOA). This trial will be sponsored through the University of Iowa.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com